Skip to main content

Table 4 Clinical characteristics of the 19 Mycobacterium avium complex lung disease patients with chronic Pseudomonas aeruginosa infection

From: Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease

No.

Age

Sex

BMI

CCI

Underlyingdisease

MACLD duration years

Hb

CRP

%FVC

%FEV1

Sputumsmear/ culturea

Cavity

Modified Reiff score

Treatment status for MACLD

Treatment regimenb

Treatment duration, years

1

74

F

17.3

0

 

10.3

13.1

1.1

99

86

- / -

+

7

Current

CAM + RFP

8.8

2

76

F

16.2

1

Old pTB, GERD

2.3

12.1

0.0

95

86

- / +

3

Never

  

3

75

M

20.2

1

LC post-lobectomy

3.2

13.8

0.5

71

55

+ / +

4

Current

CAM + EB + RFP

3.4

4

76

F

17.3

1

MCTD

2.1

11.0

0.2

94

114

- / +

5

Never

  

5

57

F

18.8

1

RA

5.3

11.7

4.2

68

54

- / -

4

Current

CAM + EB + RFP

5.2

6

69

F

26.1

0

 

15.9

13.1

0.3

78

68

- / -

+

7

Previous

CAM + RFP + EB + KM

4.3

7

77

M

21.4

1

Old pTB, ABPM

6.5

9.8

0.2

116

105

- / -

3

Never

  

8

77

F

14.9

1

 

1.9

12.2

0.0

98

102

+ / +

7

Never

  

9

67

M

18.5

0

Old pTB

2.3

14.6

0.1

112

83

- / -

1

Current

CAM + EB + RFP

2.3

10

74

F

19.5

0

 

13.0

13.5

1.2

87

75

- / -

10

Current

CAM + EB + RFP

11.4

11

81

F

18.4

0

 

14.8

11.0

0.3

103

102

+ / +

7

Never

  

12

67

F

21.2

1

RA

3.3

13.0

2.4

98

71

- / -

6

Never

  

13

73

F

18.5

0

 

9.7

10.5

5.4

80

82

- / -

+

11

Never

  

14

71

M

21.9

2

Liver cirrhosis

5.1

15.0

0.1

102

82

- / +

6

Never

  

15

69

M

16.9

0

Old pTB

6.5

12.7

1.9

58

65

- / +

+

8

Current

CAM + EB + RFP

1.7

16

77

F

20.9

1

 

9.5

12.0

5.0

92

70

- / -

2

Never

  

17

63

F

16.8

1

 

4.3

11.7

0.2

69

64

- / +

5

Current

CAM + RFP

4.1

18

74

F

21.4

1

 

0.6

13.4

0.0

106

98

- / +

2

Never

  

19

35

F

18.9

0

Chronic sinusitis

14.5

10.7

0.0

75

66

- / -

5

Current

AZM + RFP + EB

13.4

  1. BMI, body mass index; CCI, Charlson comorbidity index; MACLD, Mycobacterium avium complex lung disease; Hb, haemoglobin; CRP, C-reactive protein; FVC, forced vital capacity; FEV 1, forced expiratory volume in the first second; CAM, clarithromycin; RFP, rifampicin; pTB, pulmonary tuberculosis; GERD, gastroesophageal reflux disease; LC, lung cancer; EB, ethambutol; MCTD, mixed connective tissue disease; RA, rheumatoid arthritis; KM, kanamycin; ABPM, allergic bronchopulmonary mycosis; AZM, azithromycin;
  2. aSputum smear or culture for mycobacterium. bTreatment regimen included multiple antimicrobial therapy for MACLD